DRUG GUIDELINE

Heparin
SCOPE (Area): Acute, (Exclude: Paediatrics Seek Advice)
SCOPE (Staff): Clinical Staff
Printed versions of this document SHOULD NOT be considered up to date / current


Exclusions

Paediatrics (seek Paediatrician advice)


Preamble

See Appendix 1 for full version of this Drug Guideline


Related Documents

CPP0065 - Haemodialysis Perm Catheter Procedures
CPP0287 - Medication Administration
CPP0415 - Haemofiltration
CPP0414 - Dialysis Unit Procedures
CPG0022 - Thromboprophylaxis
DRG0030 - Protamine
CPP0542 - Drugs Used In The Dialysis Unit
CPP0222 - User Applied Labelling Of Injectable Medicines, Fluids And Lines
CPP0544 - Intravenous Drug Administration And Classification List
POL0077 - Medication Management
CPP0549 - High Risk Medications
CPP0473 - Alaris Intravenous Infusion System With Guardrails Medication And Fluid Management Software
SOP0001 - Principles Of Clinical Care


References

Alfred Health (2019, May). Therapeutic Anticoagulation with Unfractionated Heparin Guideline, Alfred Health, via personal communication.
Austin Health Clinical Guideline (2013) Heparin Guidelines [Low Molecular Weight Heparin (LMWH) and Intravenous Unfractionated Heparin (UFH)], Austin Health, via personal communication.
CRC Press, Taylor and Francis Group (2019). The Renal Drug Database. Retrieved April 10, 2019, from
Hirsh J, Raschke R. Heparin and low-molecular-weight heparin: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126:188S-203S
MIMS Australia. (2019, March). MIMS Online, Heparin product information. Retrieved March 16, 2019, from
National Heart Foundation of Australia & Cardiac Society of Australia and New Zealand. Guidelines for the management of acute coronary syndromes 2016. Retrieved April 9, 2019, from
Rossi, S. (2019, January). Australian Medicines Handbook. Retrieved March 16, 2019, from
The Royal Women’s Hospital, Victoria (2019). Pregnancy and Breastfeeding Medicines Guide. Retrieved April 10, 2019, from
The Society of Hospital Pharmacists of Australia. 2019. Australian Injectable Drugs Handbook (7th ed.). Retrieved March 13, 2019, from
Therapeutic Guidelines Limited. (2018, March). Cardiovascular Guidelines. Retrieved March 16, 2019 from
UpToDate, Inc. (2019) UpToDate. Retrieved March 16, 2019, from


Appendix

Appendix 1 - Heparin



Reg Authority: Medication Safety & Governance Committee (MSGC) Date Effective: 19/02/2020
Review Responsibility: Pharmacist - Rotational Date for Review: 30/09/2024
Heparin - DRG0038 - Version: 9 - (Generated On: 17-07-2025 05:58)